A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors
Clinical trial NCT07695142 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07695142
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-09
- Primary completion
- 2028-12-30
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.